Connect with us

Onfi (clobazam)


Clobazam (or ONFI®) is mainly prescribed to treat seizures (caused by Lennox-Gastaut syndrome) and anxiety.

Status: ACTIVE

Class: Benzodiazepine

FDA Approval: 1975

Dosage Forms: 10 mg, 20 mg

Biological Half-life: 36-42 hours

Side Effects: Dizziness, sleepiness, fever, drooling, constipation, lethargy, urticaria

Routes of Administration: Oral

Pregnancy Category: C (US)

  www.onfi.com

Advertisement

© 2018 Mental Daily. All Rights Reserved.
Our content is for informational purposes and should not be used as medical or treatment recommendation.